BridgeMD
New treatment option for Wrinkle
Official title Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
ClinicalTrials.gov ID: NCT06448676
What this study is testing
What is Botulinum toxin type A?
Botulinum toxin type A is an investigational medicine, given as an once-weekly injectable medicine, being studied as a potential treatment for wrinkle.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Study Type: This is a multicenter, triple-blind, randomized controlled trial. Purpose: The goal of this clinical trial is to compare the effectiveness and safety of all commercially available Botulinum Neurotoxin Type A (BoNT-A) products for treating glabellar rhytides, commonly known as frown lines.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Women aged 18 years or over, with moderate to severe glabellar lines
- Willing to provide written informed consent
- American Society of Anesthesiologists (ASA) Physical Status Classification 1 or 2
- Negative pregnancy test
You likely can't join if
- ASA Classification 3 or over
- History of hypersensitivity or adverse reactions to botulinum toxin or any of its components
- Infection at the injection site
- Previous treatment with botulinum toxin (lifetime)
- Pregnant or breastfeeding women
- Neuromuscular disorders or conditions that could interfere with the study assessments
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam, Netherlands
- Eindhoven, Netherlands
- Utrecht, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam, Netherlands; Eindhoven, Netherlands; Utrecht, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.